Synthesis of Rovafovir Etalafenamide (Part I): Active Pharmaceutical Ingredient Process Development, Scale-Up, and Impurity Control Strategy

工艺工程 活性成分 过程(计算) 杂质 材料科学 过程开发 化学 放大 化学工程 比例(比率) 医药制造业 机组运行 生化工程 色谱法
作者
Eric A. Standley,Dustin A. Bringley,Selçuk Çalimsiz,Jeffrey D. Ng,Keshab Sarma,Jinyu Shen,David A. Siler,Andrea Ambrosi,Wen‐Tau T. Chang,Anna Chiu,Jason A. Davy,Ian J. Doxsee,Mihaela M. Esanu,Jeffrey A. O. Garber,Youri Kim,Bernard Kwong,Olga B. Lapina,Edmund Leung,Lennie Lin,Andrew Martins,Jenny Phoenix,Jaspal Phull,Benjamin Roberts,Bing‐Feng Shi,Olivier St‐Jean,Xiang Wang,Li Wang,Nande Wright,Guojun Yu
出处
期刊:Organic Process Research & Development [American Chemical Society]
卷期号:25 (5): 1215-1236 被引量:6
标识
DOI:10.1021/acs.oprd.1c00059
摘要

This manuscript describes the chemical process development and multi-kilogram synthesis of rovafovir etalafenamide (GS-9131), a phosphonamidate prodrug nucleotide reverse transcriptase inhibitor under investigation for the treatment of HIV-1 infection. Rovafovir etalafenamide is assembled in a four-step sequence beginning from the nucleoside core and an elaborated phosphonamidate alcohol. The assembly starts with a decarboxylative elimination of a β-hydroxyacid to yield the corresponding cyclic enol ether, which is subsequently coupled to a functionalized phosphonamidate alcohol in an iodoetherification reaction. Oxidative syn elimination then installs the required fluoroalkene, after which a final deprotection reaction yields the active pharmaceutical ingredient (API). Understanding the genesis, fate, and purge of the des-fluoro analog of the API, a mitochondrial toxin, proved to be a central driver in the development of the manufacturing route and impurity control strategy. Initial control strategies revolved around the use of silica gel chromatography or simulated moving bed chromatography to purge the des-fluoro impurity to an acceptable level, but ultimately a chromatography-free approach to mitigate the formation of this impurity was devised that expanded manufacturing flexibility. Design of experiments was used to improve the iodoetherification fragment coupling reaction and to reduce the level of the des-fluoro impurity formed in this step. Furthermore, several new crystalline intermediate forms were discovered and implemented as isolation points to bolster the overall impurity control strategy for standard, diastereomeric, and potentially mutagenic impurities as well as for the des-fluoro impurity. These processes were executed on multi-kilogram scale to produce API for clinical studies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
芝士发布了新的文献求助10
2秒前
TAO完成签到,获得积分10
2秒前
3秒前
桐桐应助wang采纳,获得10
3秒前
Aimee发布了新的文献求助10
6秒前
学术垃圾制造者完成签到,获得积分10
7秒前
cc发布了新的文献求助10
8秒前
彭于晏应助科研通管家采纳,获得10
8秒前
完美世界应助科研通管家采纳,获得10
8秒前
Singularity应助科研通管家采纳,获得20
8秒前
8秒前
王旭萌发布了新的文献求助10
8秒前
大庆完成签到,获得积分10
11秒前
starofjlu应助友好凌柏采纳,获得30
12秒前
赵铁皮完成签到 ,获得积分10
13秒前
斯文败类应助青羽落霞采纳,获得10
13秒前
可爱的函函应助清爽灰狼采纳,获得10
15秒前
tyy完成签到,获得积分10
15秒前
15秒前
深情安青应助cc采纳,获得10
15秒前
chenlin完成签到,获得积分10
15秒前
15秒前
一切随风完成签到,获得积分10
16秒前
Aimee完成签到,获得积分10
16秒前
辰希完成签到,获得积分10
18秒前
18秒前
kiki发布了新的文献求助10
18秒前
FreeRice发布了新的文献求助10
18秒前
TT完成签到,获得积分10
18秒前
xf发布了新的文献求助10
19秒前
Xiaoming85完成签到,获得积分10
20秒前
allah完成签到,获得积分10
20秒前
NexusExplorer应助tyy采纳,获得10
20秒前
枫桥夜泊完成签到 ,获得积分10
21秒前
Strike发布了新的文献求助10
22秒前
SciGPT应助九九采纳,获得10
23秒前
23秒前
23秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3148173
求助须知:如何正确求助?哪些是违规求助? 2799264
关于积分的说明 7834331
捐赠科研通 2456531
什么是DOI,文献DOI怎么找? 1307282
科研通“疑难数据库(出版商)”最低求助积分说明 628124
版权声明 601655